Insider · CIK 0001535065
Kim P. Kamdar
director
Files at SERA (SERA PROGNOSTICS, INC.), OMIC (Singular Genomics Systems, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | SERA SERA PROGNOSTICS, INC. | AGrant or award Class A Common Stock | +15,596 | $0.00 | $0 | 29,342 | Jun 6, 2025 |
| Jun 5, 2025 | SERA SERA PROGNOSTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 6, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Common Stock | -15,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Common Stockindirect: By Domain Partners IX, L.P. | -3,763,985 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Common Stockindirect: By Domain Associates, LLC | -15,000 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -666 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,541 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,466 | $8.84 | $22k | 0 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.